A feasibility randomised controlled trial examining the effect of a positive mood intervention and vitamin D supplementation on the immunological responses to a boosting COVID-19 and/or influenza vaccination in healthy adults

niversity of Nottingham0 个研究点目标入组 28 人开始时间: 2024年2月8日最近更新: 2024年3月18日

适应症

试验速览

暂无简介。

•1. Able and willing to provide written informed consent to participate in the study
•2. Able and willing (in the investigator’s opinion) to comply with all the study requirements
•3. Consent to allow investigators to discuss their medical information with their general practitioner and access medical records where relevant to the study
•4. Eligible to receive a COVID-19 vaccination and/or influenza vaccination as part of usual care

•1. Enrolled on a COVID-19 vaccine clinical trial of an investigational medicinal product (CTIMP) in the last 12 months
•2. Clinically extremely vulnerable and received a third or fourth dose in Spring 2022
•3. Aged less than 65 years old
•4. Ineligible to receive a COVID-19 and/or influenza vaccination as part of usual care or those for whom a COVID-19 and/or influenza vaccination is contraindicated
•5. Collection of blood samples is contraindicated
•6. Deemed by health care provider to be:
•6.1. Too physically frail to participate.
•6.2. Diagnosed with dementia or other cognitive condition which would make participation difficult
•6.3. Insufficient command of the English language to complete surveys and provide informed consent
•6.4. Participants who, in the past 3 months, have been prescribed oral vitamin D supplementation by a health care professional or who take over-the-counter supplements regularly on the advice of a health care professional

发起方

niversity of Nottingham